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An observational study of children with sickle cell disease
in Kiliﬁ, Kenya
Recent estimates suggest that 300 000 children are born with
sickle cell disease (SCD) worldwide every year and that three-
quarters of these births occur in sub-Saharan Africa (Diallo &
Tchernia, 2002; World Health Organization [WHO] 2006).
Nevertheless, descriptions of the natural history and clinical
spectrum of SCD in Africa are surprisingly scarce and, as a
result, most treatment recommendations for the management
are based on studies conducted in resource-rich countries.
With improved access to medical care, socio-economic
development and better education, survival of patients with
SCD is improving in a number of African countries (Corachan
et al, 1979; Elamin, 1980; Knox-Macaulay, 1983; Athale &
Chintu, 1994; Koko et al, 1998). Baseline data regarding the
clinical course of SCD in this context are therefore required to
inform evidence-based decisions regarding appropriate man-
agement. This paper describes the clinical, anthropometric and
laboratory characteristics of a cohort of children with SCD
attending a specialist out-patient clinic in a rural part of
Kenya.
Methods
Study location
The study was conducted at Kiliﬁ District Hospital (KDH),
which is located 60 km to the north of Mombasa on the
Kenyan coast. KDH is the main district level government
inpatient facility, serving a community of about 100 000
children under 15 years of age. Kiliﬁ is one of the poorest
districts in Kenya, the economy being dominated by subsis-
tence agriculture (Snow et al, 1993). The prevalence of sickle
cell trait (HbAS) in this area is 15% (Williams et al, 2005) and
homozygosity for HbS (HbSS) is the only form of SCD that
has been documented in the local community.
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Summary
Globally, sickle cell disease (SCD) has its highest prevalence and worst
prognosis in sub-Saharan Africa. Nevertheless, relatively few studies describe
the clinical characteristics of children with SCD in this region. We conducted
a prospective observational study of children with SCD attending a specialist
out-patient clinic in Kiliﬁ, Kenya. A total of 124 children (median age
6Æ3 years) were included in the study. Splenomegaly was present in 41 (33%)
subjects and hepatomegaly in 25 (20%), both being common in all age
groups. A positive malaria slide was found at 6% of clinic visits. The mean
haemoglobin concentration was 73 g/l, compared to 107 g/l in non-SCD
controls (P <0 Æ001). Liver function tests were elevated; plasma bilirubin
concentrations were 46 lmol/l and aspartate aminotransferase was 124 iu/l.
Forty-eight (39%) children were admitted to hospital and two died. Children
with SCD in Kiliﬁ have a similar degree of anaemia and liver function
derangement to patients living in developed countries, but splenomegaly
persists into later childhood. The prevalence of malaria was lower than
expected given the prevalence in the local community. This study provides
valuable data regarding the clinical characteristics of children living with SCD
in a rural setting in East Africa.
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Our study involved children attending the SCD outpatient
clinic at KDH. All subjects were <14 years old at the time of
recruitment and had the diagnosis of homozygous SCD
(HbSS) conﬁrmed by alkaline haemoglobin electrophoresis.
Data on these children were collected prospectively over a
19-month period between 1 June 2003 and 31 December 2004.
Non-SCD controls were members of a longitudinal cohort
study designed to study the immunology of malaria as
described previously (Urban et al, 2006). Anthropometric
data from control subjects were collected in October 2003
(Nyakeriga et al, 2004) and blood counts performed during a
cross-sectional survey in October 2004.
Routine follow up
Children were reviewed routinely in the outpatient clinic on a
3-monthly basis and were encouraged to attend between
appointments in the event of intercurrent illness. Children who
failed to attend the clinic for more than 6 months were traced
in the community, and considered lost to follow-up if they
could not be located. Routine management included patient
education, folic acid supplementation and anti-malarial
chemoprophylaxis with proguanil. Malnutrition and anaemia
were managed according to WHO guidelines (WHO 2005).
Parents and carers of malnourished children were advised
regarding feeding and those with severe malnutrition were
admitted for in-patient hospital management. Children with
iron deﬁciency were offered ferrous sulphate and mebendazole.
Penicillin is not recommended routinely for prophylaxis
against invasive bacterial diseases in patients with SCD in
Kenya, and pneumococcal vaccines were not available at the
time of the study. Anthropometric indices (weight, height/
length and mid-upper arm circumference) were measured at
every clinic visit using standard methods (Nyakeriga et al,
2004). Routine clinical assessments (including the measure-
ment of trans-cutaneous oxygen saturation) were recorded on
standard proformas. Routine investigations included full blood
and reticulocyte counts, blood ﬁlm examination for malaria
parasites, renal and liver function tests and urine testing for
protein, blood, glucose and nitrites. Further investigations
were performed as clinically indicated. Diagnosis of suspected
bacterial infection, treatment and decision to admit were based
on WHO guidelines (WHO 2005). All patients were offered
voluntary counselling and testing for human immunodeﬁ-
ciency virus (HIV). Data regarding hospital admissions were
recorded on standard proformas.
Laboratory data
Haemoglobin was analysed by electrophoresis on cellulose
acetate gels using standard methods (Wild & Bain, 2006).
Full blood counts were performed using a Coulter MDII-18
counter (Beckman-Coulter, Fullerton CA, USA). Thick and
thin blood smears were examined for malaria parasites at
·1000 magniﬁcation using standard methods (English et al,
1996), and parasite densities were computed by comparison
to white bloods cells. Plasma concentrations of sodium and
potassium were determined using ion selective electrodes
(Ciba-Corning Diagnostics, Halstead, UK) and creatinine
concentrations with a Creatinine analyser (Beckman-Coul-
ter). Liver function tests were carried out with a Selectra-E
auto-analyser (Vital Scientiﬁc, AC Dieren, The Netherlands).
Antibodies to HIV were tested by enzyme-linked immuno-
sorbent assay (Vironostika, Biomerieux, France) and dipstick
(Determine; Abbott Laboratories, Maidenhead, UK). Positive
samples from children under 18 months of age and samples
with discordant results were assayed for proviral DNA by
polymerase chain reaction.
Ethical considerations
This study was approved by the Kenyan National Research
Ethics Committee. Written informed consent was obtained
from the parents or guardians of all subjects in their own
language.
Data handling
All data were subjected to range and consistency checks
before double-entry onto a computerised database written in
FoxPro (version 6; Microsoft, Redmond, WA, USA).
Z-scores were calculated using EpiInfo (version 3.3.2;
CDC, Atlanta, GA, USA). Statistical analyses were conducted
using the Statistical Package for the Social Sciences (spss)
(version 11.5; SPSS, Chicago, IL, USA). Means of normally
distributed data were compared using the Student’s t-test.
Categorical variables were compared using Pearson’s chi-
square or Fisher’s exact tests as indicated. P values <0Æ05
were considered signiﬁcant.
Results
A total of 124 patients were followed for a median of
13Æ8 months (range 0–18). Five hundred and eighty-three
clinic visits were recorded during the study period (median 5,
range 1–8 per patient) during a period equivalent to 118
patient-years of follow-up. Patient ages ranged from 0Æ8t o
13Æ7 years (median 6Æ3 years) at the time of recruitment.
Sixty-eight patients (55%) were male. The age and gender
distributions of the study population are shown in Fig 1. A
total of 88 admissions were recorded in 48 subjects, a rate of
0Æ45 admissions per patient per year. Amongst patients who
were admitted the median number of admissions was one
(range 1–9). At 31 December 2004, 113 (91%) patients were
alive, nine (7%) had been lost to follow up and two (2%)
had died. One child died in hospital with an aplastic crisis
and the other in the community without a cause being
identiﬁed.
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Patients reported symptoms of illness on 130 of 583 (22%)
clinic visits (Table I). There was no difference in overall
frequency of symptoms at different ages (v
2 =9 Æ909,
P =0 Æ194). Forty-one of 124 patients (33%) had clinically
detectable splenomegaly and 25 (20%) had hepatomegaly.
While both were found in all age groups, the peak prevalence
for both occurred in the 6–8 year age group where 44% of
patients had splenomegaly and 30% had hepatomegaly (Fig 2).
Among children with a palpable spleen, the median splenic size
was 3 cm below the costal margin (range 1–10 cm). In those
with a palpable liver the median liver size was 2 cm (range
1–5 cm). The largest mean spleen size of 4Æ8 cm was seen in
the 8- to 10-year age-group, and the largest mean liver size of
4Æ0 cm was seen in the 0- to 2-year age-group. However,
overall there were no signiﬁcant relationships between spleen
or liver sizes and age (P =0 Æ065 and 0Æ672 respectively). In
addition there was no relationship between splenic size and the
number of episodes of malaria (P =0 Æ072), malaria parasi-
taemia (P =0 Æ704) or use of proguanil (v
2 =3 Æ083, P =
0Æ798). One hundred and fourteen of 124 (92%) patients
reported being compliant with folic acid and proguanil
prophylaxis. Bone or joint abnormalities, including swelling
and tenderness, were found on 23 of 583 occasions (4%).
A cardiac murmur was heard on 11 occasions (2%) (never in
the same patient more than once) while skin infections were
found on two occasions.
The distributions of Z-scores for height-for-age, weight-
for-age, weight-for-height and mid upper-arm circumference-
for-age are illustrated in Fig 3. The mean weight-for-age and
weight-for-height Z-scores were both signiﬁcantly lower than
the equivalents in the local non-SCD population ()1Æ86 vs.
)1Æ47 and )1Æ10 vs. )0Æ55 respectively; P <0 Æ001). There was
no signiﬁcant difference in height-for-age Z-score between
children with SCD and controls (P =0 Æ833). Fever (deﬁned as
temperature ‡37Æ5 C) was recorded on 68 of 583 (12%) clinic
visits. Hypoxaemia (transcutaneous oxygen saturation <93%)
was recorded 36 times (6%). Five patients were hypoxaemic on
more than one clinic visit.
Investigations
The haematological details of patients and controls are
summarised in Table II. In patients with SCD, neither haemo-
globin concentration (Hb) nor mean cell volume (MCV) varied
signiﬁcantly with age (P =0 Æ331 and 0Æ595 respectively). Hb
Table I. Symptoms reported at time of clinic visit.
Age
(years)
Number (% of age group) with symptoms at the time of
clinic visit
Any
symptom Fever Pain
Cough or
difﬁculty
breathing Other
0–2 8 (28) 4 (14) 2 (7) 3 (10) 5 (17)
2–4 15 (24) 4 (6) 2 (3) 5 (8) 8 (13)
4–6 28 (27) 10 (10) 5 (5) 8 (8) 12 (12)
6–8 26 (21) 8 (6) 4 (3) 4 (3) 16 (13)
8–10 32 (27) 9 (8) 8 (7) 2 (2) 19 (16)
10–12 15 (19) 2 (3) 5 (6) 1 (1) 9 (11)
12–14 4 (8) 1 (2) 1 (2) 0 (0) 2 (4)
14–16 2 (15) 0 (0) 1 (8) 0 (0) 1 (8)
Overall 130 (22) 38 (7) 28 (5) 23 (4) 72 (12)
Age (years)
12–14 10–12 8–10 6–8 4–6 2–4 0–2
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Fig 1. Age and gender of patients attending the SCD clinic.
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Fig 2. Proportion of children with organomegaly according to age.
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signiﬁcantly higher (83Æ8 ﬂ) in children with SCD than controls
(107 g/l and 74Æ7 ﬂ respectively; P <0 Æ001). The white blood
cell count was also signiﬁcantly raised in those with SCD
comparedtocontrols(19Æ2 · 10
9/lvs.9Æ3 · 10
9/l;P <0 Æ001).A
positive malaria slide was found on 37/583 (6%) occasions: 18
patients were positive on one occasion, ﬁve on two occasions
and three on three occasions. The median parasitaemia in
patients with a positive malaria slide was 2903/ll. Ten of 37
(27%) patients with a positive malaria slide were febrile
compared with only 55 out of 535 patients (10%) with a
negative malaria slide (Fisher’s exact test, P =0 Æ005).
Liver function tests were generally elevated in the study
population. Mean (standard deviation, SD) total bilirubin was
46 (59) lmol/l and aspartate aminotransferase (AST) was 124
(36) iu/l. There was no signiﬁcant relationship between
bilirubin and age (P =0 Æ158) but AST rose with age at the
rate of 2Æ7 iu/year (P =0 Æ005). Renal function tests (sodium,
potassium and creatinine) were within normal ranges for all
patients. Urine tests were abnormal on 15 of 583 occasions
(3%). Proteinuria was detected in 11 children and microscopic
haematuria in one. One patient tested positive for proteinuria
on two separate occasions. Of the 76 patients tested for HIV
only one was positive.
Discussion
Previous descriptions of SCD from Africa have largely focused
on patients in crisis. Few studies have described the clinical
characteristics of patients with SCD at steady-state. Here we
present data on children with SCD in attendance for routine
review at a specialised out-patient clinic at Kiliﬁ District
Hospital on the Kenyan coast. While patients were also
encouraged to use the clinic during illness episodes the vast
majority of visits were for routine appointments and the
current study, therefore, represents the clinical spectrum of
SCD at steady-state in this community.
In developed countries, the spleen is often palpable in early
life due to extramedullary haematopoiesis, congestion and
sequestration (Scott & Ferguson, 1966; Powars, 1975).
Subsequent episodes of recurrent vaso-occlusion and infarc-
tion lead to gradual auto-splenectomy, and in most patients the
spleen is no longer palpable by the age of 10 years. In our
cohort splenomegaly persisted until late childhood such that
the spleen was still palpable in more than one-third of 10-year
olds, an observation that is in accordance with previous studies
conducted in sub-Saharan Africa (Esan, 1966; Adekile et al,
1988, 1993; Thuilliez & Vierin, 1997; Mouele et al, 1999). Some
reports have attributed the persistence of splenomegaly in
African children with SCD to the effects of malaria, although in
this study we did not ﬁnd an association with either the
number of episodes of malaria or level of parasitaemia. A
correlation has also been described between splenic size and
immunoglobulin levels but there are conﬂicting data as to
whether or not these antibodies are malaria-speciﬁc (Moline-
aux, 1988; Adekile et al, 1993). The majority of malaria occurs
in children aged <6 years and, given the median age of our
study population was 6Æ3 years, it is likely that only prospective
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Fig 3. Nutritional Z-scores of children attending the SCD clinic.
Median Z-scores for height-for-age, weight-for-age, weight-for-height
and mid upper-arm circumference (MUAC)-for-age were )1Æ90
(n = 123), )2Æ00 (n = 124), )1Æ50 (n = 108) and )1Æ85 (n = 43)
respectively.
oOutliers; *extremes.
Table II. Haematological parameters in SCD and non-SCD children.
Variable
SCD non-SCD
Difference* (95% CI) P value Mean (SD) N Mean (SD) N
Hb (g/l) 73 (13) 124 107 (14) 262 )34 ()37, )31) <0Æ001
Hct (%) 23Æ1( 4 Æ2) 124 32Æ5( 3 Æ9) 262 )9Æ4( )10Æ2, )8Æ6) <0Æ001
MCV (ﬂ) 83Æ8 (10Æ9) 124 74Æ7( 8 Æ7) 262 9Æ1( 6 Æ9, 111Æ3) <0Æ001
MCHC (g/l) 318 (12) 124 329 (19) 262 )11 ()14, )8) <0Æ001
WBC (·10
9/l) 19Æ2 (11Æ6) 124 9Æ3( 3 Æ5) 262 9Æ9( 7 Æ8, 12Æ0) <0Æ001
Platelets (10
9/l) 386 (169) 124 372 (156) 262 14 ()49, 21) 0Æ4354
Reticulocytes (%) 11Æ5( 6 Æ7) 119 N/A – – –
Hb, haemoglobin; Hct, haematocrit; MCV, mean cell volume; MCHC, mean cell haemoglobin concentration; WBC, white blood cells.
*Difference between means; a positive value implies value in SCD is greater, a negative value implies value in SCD is lower.
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splenomegaly and malaria in children with SCD.
The relationship between SCD and malaria is complex, and
remains the subject of some controversy. Malaria is widely
believed to be a major cause of morbidity and mortality among
children with SCD in Africa although the evidence for this is
surprisingly limited, largely based on a small series in the 1970s
(Molineaux et al, 1979). Malaria parasites do not grow well in
red blood cells from individuals with SCD in vitro, at least
under conditions of low oxygen tension (Friedman, 1978;
Pasvol et al, 1978) and, on balance, the available data from
epidemiological studies supports the conclusion that SCD may
confer moderate protection against malaria (Okuonghae et al,
1992; Aluoch, 1997; Awotua-Efebo et al, 2004). This is
supported further by the lack of evidence that widespread
chloroquine resistance has resulted in an increase in mortality
in SCD patients. At the time this study was conducted, Kiliﬁ
was meso-endemic for malaria with a typical prevalence of
symptomless Plasmodium falciparum parasitaemia in the
community of around 30% (O’Meara et al, 2008) – consid-
erably higher than the prevalence observed in our cohort of
patients with SCD (6%). The high compliance with anti-
malarial chemoprophylaxis is probably one factor; however
further studies are required to determine how much of this
difference might be explained by protection by HbS and
the particular properties of the red blood cells from children
with SCD.
The mean haemoglobin concentration in children with
SCD in our study (73 g/l) was similar to that reported in
other parts of Africa (65–83 g/l) (Onyemelukwe, 1992;
Ayatse, 1994; Diagne et al, 2000a; Rahimy et al, 2003).
Higher values of 80–90 g/l have been reported from studies
conducted in Jamaica and the USA (Serjeant et al, 1981;
Thomas & Serjeant, 1997; Miller et al, 2000; Quinn &
Ahmad, 2005), an observation that may be explained by the
higher prevalence of iron deﬁciency found in Kiliﬁ (Nyake-
riga et al, 2005). Our observation that MCV was signiﬁcantly
raised in children with SCD is consistent with previous
studies (Serjeant et al, 1981; Diop et al, 1999; Mouele et al,
1999), presumably due to the presence of a signiﬁcant
number of reticulocytes in the peripheral circulation. The
mean MCHC (mean cell haemoglobin concentration) of
318 g/l is consistent with other reports from Africa but
slightly lower than reported in Jamaica (Diop et al, 1999;
Mouele et al, 1999). It is also signiﬁcantly lower than that of
normal children from the local population. The ﬁnding of a
raised white blood cell count has been well-described in
developed countries, and has been identiﬁed as a marker of
severe SCD and, speciﬁcally, as a risk factor for early death,
stroke, acute chest syndrome and nephropathy (Okpala,
2004). Whether the same will be true in this population is, as
yet, unknown. The mean bilirubin concentration in patients
in our cohort was raised at 46 lmol/l. In steady-state SCD,
hyperbilirubinaemia is usually attributable to haemolysis
rather than hepatic disease. Other tests of liver function are
usually normal (Johnson et al, 1985; Omata et al, 1986),
although derangements at older ages have been found in
some studies (Green et al, 1953; Ferguson & Scott, 1959;
Diggs, 1965). We are not aware of any previous reports of
AST levels in steady-state African patients with SCD. One
study found that lactate dehydrogenase levels were almost
threefold higher than normal in adults and children living
with SCD in the Congo (Mouele et al, 1999), although
whether this was due to haemolysis or hepatic dysfunction is
unclear. As expected, renal function tests were normal in all
patients and the majority had a normal urine dipstick,
although proteinuria and haematuria were detected in some
older children. Ongoing follow up of this cohort will establish
how these abnormalities evolve in later childhood.
In contrast to studies from developed countries, which
have shown that from early life children with SCD are more
stunted than normal children (Serjeant & Serjeant, 2001), we
found no signiﬁcant difference in height-for-age Z-scores
between patients with SCD and local controls. In our study,
however, the mean weight-for-age and weight-for-height
Z-scores of children with SCD were both signiﬁcantly lower
than controls. This differs from a previous study in Nigeria
which found no signiﬁcant differences in height or weight of
SCD and control children with the exception of a lower
weight at 18 years of age (Oredugba & Savage, 2002). This
highlights the importance of nutritional management in
children with SCD living in an area where malnutrition is a
major cause of morbidity and mortality (Maitland et al,
2006).
Patients with SCD are predisposed to hypoxaemia through a
range of mechanisms including the lower afﬁnity of HbS for
oxygen, chronic anaemia, chest crises (Earley et al, 1998;
Ohene-Frempong et al, 1998; Kirkham et al, 2001) and
adenotonsillar hypertrophy (Ijaduola & Akinyanju, 1987;
Wittig et al, 1988). In the developed world atopy may play
an important role in nocturnal hypoxaemia, as allergic rhinitis
and asthma are common in SCD (Boyd et al, 2004). There are,
however, no data available for populations in Africa where
chronic infection is common and atopy is rare. In this study we
recorded hypoxaemia on only 6% of clinic visits, a ﬁgure
which is low compared to previous studies, in which hypox-
aemia has been reported in up to 54% of subjects (Samuels
et al, 1992; Homi et al, 1997; Setty et al, 2003; Siddiqui &
Ahmed, 2003). However, many of these studies were con-
ducted during sleep and one included both adults and
children. Performing a single measurement in the clinic is
not the ideal way to measure hypoxaemia, and some subjects
were hypoxaemic on multiple occasions. We therefore plan to
carry out overnight oxygen saturation recording to obtain a
more accurate estimate of the prevalence of nocturnal
hypoxaemia in this population.
Few previous studies have documented hospital admission
rates in African patients with SCD. A recent publication from
Nigeria quoted annual admission rates as 1Æ21 and 0Æ04 per
patient per year before and after implementation of a holistic
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of 0Æ45 per patient per year described in our study. Historically,
in many parts of Africa a marked deﬁcit of adults with SCD has
been noted relative to the numbers expected when considering
the frequencies of the trait (Lambotte-Legrand & Lambotte-
Legrand, 1955; Lehmann & Raper, 1956; Barclay et al, 1970;
Ojwang et al, 1987), suggesting that, in the past, most affected
individuals have died in childhood (Molineaux et al, 1979;
Fleming, 1989). More recently, improved survival has been
reported, and our mortality rate of 1% per year of follow up
compares favourably to that reported in Benin (7%) (Rahimy
et al, 2003) and Senegal (1Æ1%) (Diagne et al, 2000b).
Data from our cohort describe some of the similarities and
differences between children living with SCD in Africa and the
developed world. Describing the natural course of SCD in sub-
Saharan Africa will increase awareness of the massive burden of
disease and allow therapeutic interventions to be directed
effectively and efﬁciently, in particular towards the prevention
of malaria and severe anaemia and optimising nutritional
status. It is imperative that these decisions are based on data
from local populations rather than developed countries.
Further follow up of this cohort, in addition to data from
other parts of Africa, will help to provide the up to date
information required, as well as baseline data for any interven-
tion studies. In turn this will improve the outlook for the large
number of children born with SCD in Africa every year.
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